Finding 1055639 (2021-004)

Significant Deficiency
Requirement
I
Questioned Costs
$1
Year
2021
Accepted
2024-07-23

AI Summary

  • Core Issue: The organization lacked proper controls over procurement for five tested items, leading to questioned costs of $2,447.
  • Impacted Requirements: Compliance with procurement regulations outlined in 2 CFR sections 200.317-200.326 and related FAR clauses was not demonstrated.
  • Recommended Follow-Up: Management should strengthen controls to ensure all expenses align with procurement policies and maintain necessary documentation.

Finding Text

2021-004: Procurement and Suspension and Debarment: Federal Program: Assistance Listing Nos.: 14.267 Continuum of Care Program Condition: The organization was unable to demonstrate controls over the procurement for five items selected for testing. Criteria: The requirements that apply to procurement under grants and cooperative agreements are contained in 2 CFR sections 200.317 through 200.326, program legislation, federal awarding agency regulations, and the terms and conditions of the award. The requirements that apply to procurement under cost-reimbursement contracts under the FAR are contained in 48 CFR parts 03, 15, 44 and the clauses at 48 CFR sections 52.244-2, 52.244-5, 52.203-13, 52.203-16, and 52.215-12; agency FAR Supplements; and the terms and conditions of the contract. Questioned Costs: There were six expenses that no support could be provided to support the expense took place during grant period as such there is a question cost of $2,447. Effect: The Organization could have expenses that were paid that did not meet their own procurement policy. Cause: The Organization did not have good controls on ensuring the procurement requirement was meet due to staff turn over and being unable to locate documentation. Recommendation: In order to prevent future occurrences of this deficiency, we recommend that management enhance a set of controls to ensure that they are able to demonstrate that all expenses meet their procurement policy. Perspective: This is a systemic issue in that controls over the requirement are not being adhered to ensure no issues arise. Repeat: This is not a repeat finding. Responsible Official’s View: The Organization agrees with the finding. See attached corrective action plan.

Categories

Questioned Costs Procurement, Suspension & Debarment

Other Findings in this Audit

  • 479185 2021-001
    Significant Deficiency
  • 479186 2021-001
    Significant Deficiency
  • 479187 2021-001
    Significant Deficiency
  • 479188 2021-001
    Significant Deficiency
  • 479189 2021-002
    Significant Deficiency
  • 479190 2021-002
    Significant Deficiency
  • 479191 2021-002
    Significant Deficiency
  • 479192 2021-002
    Significant Deficiency
  • 479193 2021-003
    Significant Deficiency
  • 479194 2021-003
    Significant Deficiency
  • 479195 2021-003
    Significant Deficiency
  • 479196 2021-003
    Significant Deficiency
  • 479197 2021-004
    Significant Deficiency
  • 479198 2021-004
    Significant Deficiency
  • 479199 2021-004
    Significant Deficiency
  • 479200 2021-004
    Significant Deficiency
  • 479201 2021-005
    Significant Deficiency
  • 479202 2021-005
    Significant Deficiency
  • 479203 2021-005
    Significant Deficiency
  • 479204 2021-005
    Significant Deficiency
  • 479205 2021-005
    Significant Deficiency
  • 479206 2021-005
    Significant Deficiency
  • 479207 2021-005
    Significant Deficiency
  • 1055627 2021-001
    Significant Deficiency
  • 1055628 2021-001
    Significant Deficiency
  • 1055629 2021-001
    Significant Deficiency
  • 1055630 2021-001
    Significant Deficiency
  • 1055631 2021-002
    Significant Deficiency
  • 1055632 2021-002
    Significant Deficiency
  • 1055633 2021-002
    Significant Deficiency
  • 1055634 2021-002
    Significant Deficiency
  • 1055635 2021-003
    Significant Deficiency
  • 1055636 2021-003
    Significant Deficiency
  • 1055637 2021-003
    Significant Deficiency
  • 1055638 2021-003
    Significant Deficiency
  • 1055640 2021-004
    Significant Deficiency
  • 1055641 2021-004
    Significant Deficiency
  • 1055642 2021-004
    Significant Deficiency
  • 1055643 2021-005
    Significant Deficiency
  • 1055644 2021-005
    Significant Deficiency
  • 1055645 2021-005
    Significant Deficiency
  • 1055646 2021-005
    Significant Deficiency
  • 1055647 2021-005
    Significant Deficiency
  • 1055648 2021-005
    Significant Deficiency
  • 1055649 2021-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
16.576 Crime Victim Compensation $301,041
14.267 Continuum of Care Program $57,267
16.575 Crime Victim Assistance $33,903
94.006 Americorps $31,745
16.588 Violence Against Women Formula Grants $26,813
93.788 Opioid Str $16,911
93.994 Maternal and Child Health Services Block Grant to the States $15,472
10.558 Child and Adult Care Food Program $14,904
93.558 Temporary Assistance for Needy Families $6,167